In vitro exposure of MS patient–derived ILCs to estriol and commensal bacterial strains (Escherichia coli K12 and Lactobacillus plantarum 8R-A3) induced regulatory ILC transitions, enhancing anti-inflammatory phenotypes (65). Here, CCL27 is linked to myeloid sarcoma.